Literature DB >> 18539110

Hematopoietic lineage commitment: miRNAs add specificity to a widely expressed transcription factor.

Paloma García1, Jon Frampton.   

Abstract

MicroRNAs are important regulators of normal and malignant hematopoiesis. A paper by Lu et al. in this issue of Developmental Cell demonstrates how one microRNA, miR-150, plays a critical role in commitment of the erythroid-megakaryocyte progenitor by modulating the level of the widely expressed transcription factor MYB (or c-Myb).

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18539110     DOI： 10.1016/j.devcel.2008.05.011

Source DB:  PubMed          Journal:  Dev Cell        ISSN： 1534-5807            Impact factor:   12.270


  11 in total

1.  The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia.

Authors:  S P Whitman; M A Caligiuri; K Maharry; M D Radmacher; J Kohlschmidt; H Becker; K Mrózek; Y-Z Wu; S Schwind; K H Metzeler; J H Mendler; J Wen; M R Baer; B L Powell; T H Carter; J E Kolitz; M Wetzler; A J Carroll; R A Larson; G Marcucci; C D Bloomfield
Journal:  Leukemia       Date:  2012-02-07       Impact factor: 11.528

Review 2.  Hematopoietic stem cells and retroviral infection.

Authors:  Prabal Banerjee; Lindsey Crawford; Elizabeth Samuelson; Gerold Feuer
Journal:  Retrovirology       Date:  2010-02-04       Impact factor: 4.602

Review 3.  MicroRNAs: control and loss of control in human physiology and disease.

Authors:  Min Li; Christian Marin-Muller; Uddalak Bharadwaj; Kwong-Hon Chow; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

4.  Reduced c-Myb activity compromises HSCs and leads to a myeloproliferation with a novel stem cell basis.

Authors:  Paloma García; Mary Clarke; Alexandros Vegiopoulos; Oscar Berlanga; Ana Camelo; Maelle Lorvellec; Jon Frampton
Journal:  EMBO J       Date:  2009-04-09       Impact factor: 11.598

5.  Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia.

Authors:  Marcia Bellon; Yves Lepelletier; Olivier Hermine; Christophe Nicot
Journal:  Blood       Date:  2009-02-26       Impact factor: 22.113

Review 6.  Myb proteins: angels and demons in normal and transformed cells.

Authors:  Ye Zhou; Scott A Ness
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

7.  Constitutive Expression of miR408 Improves Biomass and Seed Yield in Arabidopsis.

Authors:  Zhaoqing Song; Lifen Zhang; Yulong Wang; Haixia Li; Shuang Li; Huijie Zhao; Huiyong Zhang
Journal:  Front Plant Sci       Date:  2018-01-25       Impact factor: 5.753

8.  Ferritin Heavy Subunit Silencing Blocks the Erythroid Commitment of K562 Cells via miR-150 up-Regulation and GATA-1 Repression.

Authors:  Fabiana Zolea; Anna Martina Battaglia; Emanuela Chiarella; Donatella Malanga; Carmela De Marco; Heather Mandy Bond; Giovanni Morrone; Francesco Costanzo; Flavia Biamonte
Journal:  Int J Mol Sci       Date:  2017-10-17       Impact factor: 5.923

9.  A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function.

Authors:  Nicole Soranzo; Augusto Rendon; Christian Gieger; Chris I Jones; Nicholas A Watkins; Stephan Menzel; Angela Döring; Jonathan Stephens; Holger Prokisch; Wendy Erber; Simon C Potter; Sarah L Bray; Philippa Burns; Jennifer Jolley; Mario Falchi; Brigitte Kühnel; Jeanette Erdmann; Heribert Schunkert; Nilesh J Samani; Thomas Illig; Stephen F Garner; Angela Rankin; Christa Meisinger; John R Bradley; Swee Lay Thein; Alison H Goodall; Tim D Spector; Panos Deloukas; Willem H Ouwehand
Journal:  Blood       Date:  2009-02-12       Impact factor: 22.113

10.  Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells.

Authors:  I Iosue; R Quaranta; S Masciarelli; G Fontemaggi; E M Batassa; C Bertolami; T Ottone; M Divona; B Salvatori; F Padula; A Fatica; F Lo-Coco; C Nervi; F Fazi
Journal:  Cell Death Dis       Date:  2013-11-21       Impact factor: 8.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.